Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-09-2010 | Original Paper

Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer

Authors: Hua Hu, Yang Zhang, Mei Zou, Shuai Yang, Xiao-Qiu Liang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2010

Abstract

Purpose

Telomere dysfunction is believed to be a significant factor in carcinogenesis. To elucidate the carcinogenesis mechanism in gastric cancer, the expression of telomeric proteins and changes in telomere length were investigated during multistage carcinogenesis of gastric cancer.

Methods

Tissue samples were obtained during surgical operations from the normal gastric mucosa of 10 patients, the precancerous lesions of 15 patients, the gastric cancer tissues (GC) of 20 patients, and of tumors due to gastric cancer with lymph node metastasis (GCLM) from 5 patients. The expression of TRF1, TRF2, and TIN2 proteins was measured by Western blotting, while the expression of TERT, KU70, and BRCA1 proteins was detected using the immunohistochemical method. The mean telomere length was determined by Southern blotting.

Results

Compared with normal gastric mucosa tissues, the expression of TRF1, TRF2, and TIN2 proteins was significantly higher in precancerous lesions, GC, and GCLM (P < 0.01). The expression of TRF1, TRF2, and TIN2 proteins was significantly higher in GC and GCLM than in precancerous lesions (P < 0.01). The expression of TERT and Ku70 proteins in precancerous lesions and GC tissues was significantly higher than that in normal gastric mucosa tissues (P < 0.01). The expression of TERT and Ku70 proteins in GC tissues was significantly higher than in precancerous lesions (P < 0.01). In normal gastric mucosa, the BRCA1 protein was primarily located in the cell nucleus. In precancerous lesions and GC, the expression of the BRCA1 protein was apparent in the cell cytoplasm. The mean telomere length in precancerous lesions, GC, and GCLM was significantly shorter than that in normal gastric mucosa tissues (P < 0.05). The mean telomere length in GC and GCLM was significantly shorter than that in precancerous lesions (P < 0.05). The mean telomere length in all tissue samples was inversely correlated with the level of TRF1, TRF2, TIN2, TERT, and Ku70 proteins.

Conclusions

Our results suggest that the over-expression of telomeric proteins, TRF1, TRF2, TIN2, TERT, and Ku70, and the transposition of the BRCA1 protein may work together to reduce the telomere length in precancerous lesions and gastric cancer, and could contribute to the multistage carcinogenesis of gastric cancer. These findings offer new insight into the mechanism of carcinogenesis in gastric cancer.

Autexier C, Lue NF (2006) The structure and function of telomerase reverse transcriptase. Annu Rev Biochem 75:493–517. doi:10.1146/annurev.biochem.75.103004.142412 CrossRefPubMed

Bellon M, Datta A, Brown M et al (2006) Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia. Int J Cancer 119(9):2090–2097. doi:10.1002/ijc.22026 CrossRefPubMed

Blackburn EH (1991) Structure and function of telomeres. Nature 350(6319):569–573. doi:10.1038/350569a0 CrossRefPubMed

Blasco MA (2005) Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6(8):611–622. doi:10.1038/nrg1656 CrossRefPubMed

Broccoli D, Smogorzewska A, Chong L et al (1997) Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 17(2):231–235. doi:10.1038/ng1097-231 CrossRefPubMed

Celli GB, Denchi EL, de Lange T et al (2006) Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat Cell Biol 8(8):885–890. doi:10.1038/ncb1444 CrossRefPubMed

Chai W, Ford LP, Lenertz L et al (2002) Human Ku70/80 associates physically with telomerase through interaction with Htert. J Biol Chem 277(49):47242–47247. doi:10.1074/jbc.M208542200 CrossRefPubMed

Chen J, Rocken C, Malfertheiner P et al (2004) Recent advances in molecular diagnosis and therapy of gastric cancer. Dig Dis 22:380–385. doi:10.1159/000083602 CrossRefPubMed

Chen LY, Liu D, Songyang Z et al (2007) Telomere Maintenance through Spatial Control of Telomeric Proteins. Mol Cell Biol 27(16):5898–5909. doi:10.1128/MCB.00603-07 CrossRefPubMed

Cook BD, Dynek JN, Chang W et al (2002) Role for the related poly(ADP-ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol Cell Biol 22:332–342. doi:10.1128/MCB.22.1.332-342.2002 CrossRefPubMed

Cornelis RS, Neuhausen SL, Johannson O et al (1995) High allele loss rates at 17q12–q21 in breast and ovarian tumors from BRCA1-linked families. the Breast Cancer Linkage Consortium. Genes Chromosom Cancer 13:203–210. doi:10.1002/gcc.2870130310 CrossRefPubMed

Dahse R, Fiedler W, Junker K et al (1999) Telomerase activity and telomere lengths: alterations in renal cell carcinomas. Kidney Int 56(4):1289–1290. doi:10.1046/j.1523-1755.1999.00688.x CrossRefPubMed

de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19(18):2100–2110. doi:10.1101/gad.1346005 CrossRefPubMed

Garcia-Aranda C, de Juan C, Diaz-Lopez A et al (2006) Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma. Cancer 106(3):541–551. doi:10.1002/cncr.21625 CrossRefPubMed

Hahn WC (2003) Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 21(10):2034–2043. doi:10.1200/JCO.2003.06.018 CrossRefPubMed

Hsu HL, Gilley D, Blackburn EH et al (1999) Ku is associated with the telomere in mammals. Proc Natl Acad Sci USA 96(22):12454–12458. doi:10.1073/pnas.96.22.12454 CrossRefPubMed

Hu J, Sun L, Zhang C et al (2006) Expression of telomeric repeat binding factor 1 in non-small cell lung cancer. J Surg Oncol 93(1):62–67. doi:10.1002/jso.20421 CrossRefPubMed

Kim SH, Kaminker P, Campisi J et al (1999) TIN2, a new regulator of telomere length in human cells. Nat Genet 23(4):405–412. doi:10.1038/70508 CrossRefPubMed

Kim HR, Kim YJ, Kim HJ et al (2002) Telomere length changes in colorectal cancers and polyps. J Korean Med Sci 17(3):360–365PubMed

Li B, Oestreich S, de Lange T et al (2000) Identification of human Rap1: implications for telomere evolution. Cell 101:471–483. doi:10.1016/S0092-8674(00)80858-2 CrossRefPubMed

Li H, Lee TH, Avraham H et al (2002) A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. J Biol Chem 277(23):20965–20973. doi:10.1074/jbc.M112231200 CrossRefPubMed

Miyachi K, Fujita M, Tanaka N et al (2002) Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer. J Exp Clin Cancer Res 21(2):269–275PubMed

Neuhausen SL, Marshall CJ (1994) Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res 54:6069–6072PubMed

Oh BK, Kim YJ, Park C et al (2005) Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis. Am J Pathol 166(1):73–80PubMed

Poncet D, Belleville A, t’kint de Roodenbeke C et al (2008) Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood 111(4):2388–2391. doi:10.1182/blood-2007-09-111245 CrossRefPubMed

Reddel RR, Bryan TM, Colgin LM et al (2001) Alternative lengthening of telomeres in human cells. Radiat Res 155(1 Pt 2):194–200. doi:10.1667/0033-7587(2001)155[0194:ALOTIH]2.0.CO;2 CrossRefPubMed

Smith S, de Lange T (1997) TRF1, a mammalian telomeric protein. Trends Genet 13(1):21–26. doi:10.1016/S0168-9525(96)10052-4 CrossRefPubMed

Smogorzewska A, van Steensel B, Bianchi A et al (2000) Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20(5):1659–1668. doi:10.1128/MCB.20.5.1659-1668.2000 CrossRefPubMed

Song K, Jung D, Jung Y et al (2000) Interaction of human Ku70 with TRF2. FEBS Lett 481(1):81–85. doi:10.1016/S0014-5793(00)01958-X CrossRefPubMed

Stansel RM, de Lange T, Griffith JD (2001) T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 20:5532–5540. doi:10.1093/emboj/20.19.5532 CrossRefPubMed

van Steensel Band de Lange T (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385(6618):740–743. doi:10.1038/385740a0 CrossRef

Wainwright LJ, Middleton PG, Rees JL et al (1995) Changes in mean telomere length in basal cell carcinomas of the skin. Genes Chromosom Cancer 12(1):45–49. doi:10.1002/gcc.2870120108 CrossRefPubMed

Xiong J, Fan S, Meng Q et al (2003) BRCA1 inhibition of telomerase activity in cultured cells. Mol Cell Biol 23(23):8668–8690. doi:10.1128/MCB.23.23.8668-8690.2003 CrossRefPubMed

Yamada M, Tsuji N, Nakamura M et al (2002) Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res 22(6A):3303–3307PubMed

Ye JZ, Donigian JR, van Overbeek M et al (2004) TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem 279(45):47264–47271. doi:10.1074/jbc.M409047200 CrossRefPubMed

Zhou XZ, Lu KP (2001) The Pin2/TRF1 interacting protein PinX1 is a potent telomerase inhibitor. Cell 107:347–359. doi:10.1016/S0092-8674(01)00538-4 CrossRefPubMed

Zhu XD, Kuster B, Mann M et al (2000) Cellcycle-regulated association of Rad50/MRE11/NBS1 with TRF2 and human telomeres. Nat Genet 25:347–352. doi:10.1038/77139 CrossRefPubMed

Title: Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer
Authors: Hua Hu
Yang Zhang
Mei Zou
Shuai Yang
Xiao-Qiu Liang
Publication date: 01-09-2010
Publisher: Springer-Verlag
Published in: Journal of Cancer Research and Clinical Oncology / Issue 9/2010
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-010-0795-x

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2010

Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients

Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation

Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid B

The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort

Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients

Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page